@prefix p: <http://www.wikidata.org/prop/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema1: <http://schema.org/> .
@prefix wd: <http://www.wikidata.org/entity/> .
@prefix wds: <http://www.wikidata.org/entity/statement/> .
@prefix wdt: <http://www.wikidata.org/prop/direct/> .
@prefix wikibase: <http://wikiba.se/ontology#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

wd:Q47477264 rdfs:label "Un estudi aleatoritzat de fase III d'ABI-007 Plus Gemcitabina setmanal versus gemcitabina sola en pacients amb adenocarcinoma metastàtic del pàncrees"@ca,
        "A Randomized Phase III Study of Weekly ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Adenocarcinoma of the Pancreas"@en ;
    schema1:dateModified "2024-11-21T17:34:33+00:00"^^xsd:dateTime ;
    schema1:description "Càncer de pàncrees metastàtic fase III d'investigació d'assaigs clínics"@ca,
        "clinical trail researching phase III metastatic pancreatic cancer"@en ;
    schema1:version 2277998061 ;
    wikibase:identifiers 1 ;
    wikibase:sitelinks 0 ;
    wikibase:statements 21 ;
    p:P1011 wds:Q47477264-54542a35-4ba4-bc2e-123a-0dcb426da215 ;
    p:P1012 wds:Q47477264-2eda32ba-4674-38e3-30d5-b23a00d3c4a8,
        wds:Q47477264-759f89d6-4323-32b5-7249-90fc907e7216,
        wds:Q47477264-9e9e1bc6-440b-6e9e-67a4-49f3bf585e16,
        wds:Q47477264-bb696e70-43ed-90ea-4c91-e9802c30e2f3,
        wds:Q47477264-c48be372-4a10-aaf0-5acd-2de79dde0478,
        wds:Q47477264-eaaa98d7-4616-abdc-f7ed-6823c1708b4e ;
    p:P1132 wds:Q47477264-2cf5dc1b-4169-a440-c493-4bf43ccc0551 ;
    p:P131 wds:Q47477264-44bd9287-4797-49bf-f3b2-c421d266f747,
        wds:Q47477264-d34b3fd9-4594-8e9d-1639-c4f5e87891a5 ;
    p:P17 wds:Q47477264-8017060D-FE11-4CE0-A486-5F410AAD1579 ;
    p:P2899 wds:Q47477264-9e41301f-49c4-c8a0-f2cf-9bf9c8650745 ;
    p:P3098 wds:Q47477264-7d6d0e20-485e-98ed-5c84-7f7e0752a2d9 ;
    p:P3712 wds:Q47477264-f6a0fbb5-472c-f174-c0fc-85cfd8945a87 ;
    p:P4135 wds:Q47477264-9e387a48-42fc-60a3-c791-9e7afed2819c ;
    p:P437 wds:Q47477264-c08653f4-4684-ff88-b42d-074db858ad45 ;
    p:P4844 wds:Q47477264-6597851F-A544-4D29-9CD5-37CE549BFF3A ;
    p:P580 wds:Q47477264-f070015b-4c55-493c-9d60-85b81c378216 ;
    p:P582 wds:Q47477264-a3e7e3ed-40a9-df85-345b-09f206c52fe5 ;
    p:P856 wds:Q47477264-ed9a6f49-4e8a-6aa6-137b-b780d78464c4 ;
    p:P859 wds:Q47477264-65509806-4429-34b3-583a-2b7f0a18868b ;
    wdt:P1011 wd:Q181600 ;
    wdt:P1012 wd:Q16644043,
        wd:Q181600,
        wd:Q6581072,
        wd:Q6581097 ;
    wdt:P1132 861.0 ;
    wdt:P131 wd:Q33534124,
        wd:Q492318 ;
    wdt:P17 wd:Q30 ;
    wdt:P2899 18.0 ;
    wdt:P3098 "NCT00844649" ;
    wdt:P3712 wd:Q179661 ;
    wdt:P4135 79.0 ;
    wdt:P437 wd:Q1436668 ;
    wdt:P4844 wd:Q414143 ;
    wdt:P580 "2009-03-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P582 "2012-09-01T00:00:00+00:00"^^xsd:dateTime ;
    wdt:P856 <https://clinicaltrials.gov/ct2/show/NCT00844649> ;
    wdt:P859 wd:Q842947 .